Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: A Wisconsin oncology network study
Saurabh Rajguru, Thorhildur Kristinsdottir, Jens Eickhoff, Chris Peterson, Christine M. Meyer, Anne M. Traynor, Brad S. Kahl
Dive into the research topics of 'Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: A Wisconsin oncology network study'. Together they form a unique fingerprint.